pISSN 2234-3806
eISSN 2234-3814

Fig. 1. Study overview. This study involved 53 patients with metastatic PDAC. ctDNA was analyzed in blood samples at baseline and post-chemotherapy. The primary objective was to explore the prognostic value of residual ctDNA on survival.
Abbreviation: ctDNA, circulating tumor DNA.

Ann Lab Med 2025;45:199~208 https://doi.org/10.3343/alm.2024.0345